Boothbay Fund Management’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $356K | Hold |
177,858
| – | – | 0.01% | 855 |
|
|
2025
Q1 | $445K | Buy |
177,858
+155,443
| +693% | +$389K | 0.01% | 752 |
|
|
2024
Q4 | $66.1K | Buy |
+22,415
| New | +$66.1K | ﹤0.01% | 1166 |
|
|
2023
Q4 | – | Sell |
-46,895
| Closed | -$246K | – | 1828 |
|
|
2023
Q3 | $246K | Buy |
+46,895
| New | +$246K | 0.01% | 1156 |
|
|
2022
Q2 | – | Sell |
-2,545
| Closed | -$95K | – | 2334 |
|
|
2022
Q1 | $95K | Buy |
2,545
+1,016
| +66% | +$37.9K | ﹤0.01% | 1726 |
|
|
2021
Q4 | $89K | Sell |
1,529
-402
| -21% | -$23.4K | ﹤0.01% | 1562 |
|
|
2021
Q3 | $159K | Sell |
1,931
-2,316
| -55% | -$191K | ﹤0.01% | 1407 |
|
|
2021
Q2 | $401K | Sell |
4,247
-5,777
| -58% | -$545K | 0.01% | 975 |
|
|
2021
Q1 | $641K | Sell |
10,024
-5,557
| -36% | -$355K | 0.02% | 655 |
|
|
2020
Q4 | $907K | Buy |
+15,581
| New | +$907K | 0.03% | 434 |
|